Gujarat Themis Biosyn Limited
Gujarat Themis Biosyn Limited engages in the manufacture of pharmaceuticals and medicinal chemicals in India. The company offers bulk drugs on job work basis in India. Its products include Rifamycin-S, an intermediate for the treatment of tuberculosis, Mycobacterium avium complex, leprosy, and Legionnaires' disease; Rifamycin-O for the treatment of traveler's diarrhea, irritable bowel syndrome, a… Read more
Market Cap & Net Worth: Gujarat Themis Biosyn Limited (GUJTHEM)
Gujarat Themis Biosyn Limited (NSE:GUJTHEM) has a market capitalization of $348.65 Million (₹30.19 Billion) as of March 18, 2026. Listed on the NSE stock exchange, this India-based company holds position #18328 globally and #875 in its home market, demonstrating a -7.01% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Gujarat Themis Biosyn Limited's stock price ₹277.10 by its total outstanding shares 108965265 (108.97 Million).
Gujarat Themis Biosyn Limited Market Cap History: 2025 to 2026
Gujarat Themis Biosyn Limited's market capitalization history from 2025 to 2026. Data shows growth from $555.69 Million to $348.65 Million (0.00% CAGR).
Gujarat Themis Biosyn Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Gujarat Themis Biosyn Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.37x
Gujarat Themis Biosyn Limited's market cap is 0.37 times its annual revenue
1.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
1.14x
Gujarat Themis Biosyn Limited's market cap is 1.14 times its annual earnings
10.29x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $555.69 Million | $1.51 Billion | $487.72 Million | 0.37x | 1.14x |
Competitor Companies of GUJTHEM by Market Capitalization
Companies near Gujarat Themis Biosyn Limited in the global market cap rankings as of March 18, 2026.
Key companies related to Gujarat Themis Biosyn Limited by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #423 globally with a market cap of $51.97 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #455 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #423 | Zoetis Inc | NYSE:ZTS | $51.97 Billion | $118.15 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.46 |
| #455 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Gujarat Themis Biosyn Limited Historical Marketcap From 2025 to 2026
Between 2025 and today, Gujarat Themis Biosyn Limited's market cap moved from $555.69 Million to $ 348.65 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₹348.65 Million | -37.26% |
| 2025 | ₹555.69 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Gujarat Themis Biosyn Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $348.65 Million USD |
| MoneyControl | $348.65 Million USD |
| MarketWatch | $348.65 Million USD |
| marketcap.company | $348.65 Million USD |
| Reuters | $348.65 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.